MISCELLANEOUS LAWS
369
MISCELLANEOUS LAWS
LEGEND DRUGS; ANABOLIC
STEROIDS
TITLE 16
ARTICLE 18
Chapter 2. Definitions [Portions omitted].
16-18-2-5.5.
“Adult stem cell” defined.
16-18-2-15.
“Anabolic steroid” defined.
16-18-2-56.5.
“Cloning” defined.
16-18-2-78.
“Controlled premises” defined.
16-18-2-79.
“Controlled substance” defined.
16-18-2-101.
“Drug” defined.
16-18-2-102.
“Drug order” defined.
16-18-2-103.
“Drug sample” defined.
16-18-2-128.5. “Fetal stem cell” defined.
16-18-2-183.5. “Human embryo” defined.
16-18-2-194.
“Investigational or new drug” defined.
16-18-2-199.
“Legend drug” defined.
16-18-2-216.
“Manufacturer” defined.
16-18-2-223.
“Mechanical device” defined.
16-18-2-281.
“Pharmacist” defined.
16-18-2-288.
“Practitioner” defined.
16-18-2-289.
“Precursor” defined.
16-18-2-292.
“Prescription” defined.
16-18-2-321.
“Sale” defined.
16-18-2-365.
“Viability” defined.
16-18-2-374.
“Wholesaler” defined.
16-18-2-5.5. “Adult stem cell” defined.
“Adult stem cell”means an undifferentiated cell
that:
(1) is found in a differentiated tissue;
(2) is renewable; and
(3) yields specialized cell types with cer-
tain limitations of the tissue from which it
originated.
16-18-2-15. “Anabolic steroid” defined.
“Anabolic steroid,” ,” for purposes of IC 16-
42-19, means a material, compound, mixture, or
preparation that contains an anabolic steroid that
includes any of the following:
Chorionic gonadotropin
Clostebol
Dehydrochlormethyltestosterone
Ethylestrenol
Fluoxymesterone
Mesterolone
Metenolone
Methandienone
Methandro stenolone
Methyltestosterone
Nandrolone decanoate
Nandrolone phenpropionate
Norethandrolone
Oxandrolone
Oxymesterone
Oxymetholone
Stanozolol
Testosterone propionate
Testosterone-like related compounds.
16-18-2-56.5. “Cloning” defined.
(a) “Cloning” means the use of asexual repro-
duction to create or grow a human embryo from
a single cell or cells of a genetically identical
human.
(b) The term does not include:
(1) a treatment or procedure to enhance
human reproductive capability through the
manipulation of human oocytes or
embryos, including the following:
(A) In vitro fertilization.
(B) Gamete intrafallopian transfer.
(C) Zygote intrafallopian transfer; or
(2) the following types of stem cell
research:
(A) Adult stem cell.
(B) Fetal stem cell, as long as the bio-
logical parent has given written consent
for the use of the fetal stem cells.
(C) Embryonic stem cells from lines
that are permissible for use under appli-
cable federal law.
16-18-2-78. “Controlled premises” defined.
“Controlled premises,” for purposes of IC 16-
42-20-2, has the meaning set forth in IC 16-42-20-
2(a).
16-18-2-79. “Controlled substance” defined.
“Controlled substance,” for purposes of IC
16-42-21, has the meaning set forth in IC 16-42-
21-1.
16-18-2-101. “Drug” defined.
(a) “Drug,” for purposes of IC 16-42-1 through
